Physician profile
Roma Patel
NPI 1639760481
$1,716.60
in general payments reported to CMS, 2019-2025
9 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $596 · 2023: $236 · 2024: $367 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $482.24 | 2023-2025 | Carto 3, Qdot Micro |
| Janssen Pharmaceuticals, INC | $326.71 | 2022-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.55 | 2021-2022 | |
| Novo Nordisk INC | $197.23 | 2022-2025 | Ozempic |
| Boston Scientific Corporation | $164.17 | 2022-2024 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $159.63 | 2022-2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $122.44 | 2022-2024 | Camzyos |
| Amgen INC. | $25.80 | 2024 | Repatha |
| Medtronic, INC. | $16.83 | 2025 | Azure Xt Dr Mri Surescan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roma Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.